A.O. Ospedale Papa Giovanni XXIII: Clinical Trials

63 trials sponsored by A.O. Ospedale Papa Giovanni XXIII, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

24 unknown, 20 completed, 11 recruiting, 5 terminated. 10 Phase 4, 9 Not applicable, 9 Phase 2, 8 Phase 3, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 410Unknown 7, Completed 3
Not applicable9Completed 3, Recruiting 2, Active not recruiting 1, Terminated 1, Unknown 1, Withdrawn 1
Phase 29Unknown 3, Completed 2, Recruiting 2, Terminated 2
Phase 38Completed 5, Unknown 2, Terminated 1
Phase 14Unknown 3, Terminated 1

Follow A.O. Ospedale Papa Giovanni XXIII: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Validation of the Italian SCHFI v.8 and the CC-SCHFI v.3
Administration of the Italian version of the SCHFI and the CC-SCHFI, plus other self-reported ouctome measures - Heart Failure
Not yet recruitingCentro Cardiologico Monzino10002026-05-012026-05-27
Antenatal Stress and Infants In MAR
Diagnostic procedures - Pregnancy and Medically Assisted Reproduction
RecruitingIRCCS Eugenio Medea1002026-04-012026-02-13
Three Different GHDT ( Goal Hemodynamic Directed Therapy) Strategies for Intraoperative Fluid Management Optimization During Major Abdominal Surgery: A Randomized Controlled Trial
Flotrac sensor, HPI, HPI-AFM - Hemodynamic
Not applicableRecruitingASST Sette Laghi1502026-03-022026-03-25
Patients With Severe TrIcuspid Regurgitation After triCvALve System Implantation
TricValve implantation - Severe Tricuspid Valve Regurgitation
RecruitingAzienda Ospedaliero, Universitaria Pisana1002025-02-012026-05-11
Trauma Molecular Processes
Traumatic Brain Injury
RecruitingMario Negri Institute for Pharmacological Research5002024-10-182026-07-06
Post-Partum Haemorrhage (PPH) Improvement of Skills With Actor Simulations
teamwork job improvement overall, teamwork job improvement in actor scenario vs mannequin scenario - PPH - Postpartum Hemorrhage
UnknownG. d'Annunzio University502024-05-012024-04-16
Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological Therapy
radioembolization with Y-90, Durvalumab, Cisplatin - Intrahepatic Cholangiocarcinoma
Phase 2RecruitingFrancesco De Cobelli332024-04-302026-09-21
Mesenchymal Stromal Cells for Traumatic Brain Injury
Mesenchymal stromal cell low dosage-80*10^6 cells, Mesenchymal stromal cell low dosage-160*10^6 cells, Placebo-storage solution - Traumatic Brain Injury With Loss of Consciousness
Phase 2RecruitingFondazione IRCCS San Gerardo dei Tintori782023-09-192023-12-11
ThoRAciC Trauma IntubatiON Risk Score for Blunt Trauma
oro tracheal intubation - Trauma Chest
UnknownAzienda Usl di Bologna10002022-10-012024-01-31
Upfront Surgery Versus NeoAdjuvant Chemotherapy Followed by Surgery for Resectable Advanced Gastric Cancer: SNAC Study
pre- or perioperative treatment and D2 gastrectomy - Gastric Cancer
UnknownSan Luigi Gonzaga Hospital6842022-09-222024-06-24
Lung Cancer Prevention Screening Programme in Italy
early lung cancer detection, blood test - Lung Cancer, COPD (Chronic Obstructive Pulmonary Disease) With Acute Lower Respiratory Infection
Not applicableActive not recruitingUgo Pastorino73242022-09-172026-03-27
OPTImal PHARMacological Therapy for Patients With Heart Failure: The OPTIPHARM-HF Registry
Heart Failure
UnknownAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia20002022-07-182024-01-05
Registry for Evaluation of Lumbar Arthrodesis Sagittal alignmEnt
Lumbar Spine Disease, Instabilities Lumbar
UnknownUnit of neurosurgery, Departement of Neurosciences, University of Torino5002022-06-012023-12-04
This Study Aims to Improve the Stratification of Patients With Acute Myeloid Leukemia to Enable More Personalized and Effective Treatments, and to Identify and Functionally Validate, at the Single-cell Level, Biomarkers That Can Predict Response to Venetoclax.
Bulk genotyping of AML samples at diagnosis and relapse, scRNA analysis at diagnosis, scRNAseq and genotyping analysis at day 28 after therapy, spatial transcriptomic analysis at day 0 and 28 - Acute Myeloid Leukemia
Not applicableRecruitingFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico4202022-05-102026-10-21
WEANING FROM TRACHEOSTOMY
Decannulation - Tracheostomy Weaning, Tracheostomy Decannulation
CompletedUniversity of Milan1922022-04-012025-09-10
Poor Grade Aneurysmal Subarachnoid Hemorrhage Study Group
Standard management according to international/national guidelines - Subarachnoid Hemorrhage, Aneurysmal, Poor Grade Subarachnoid Hemorrhage
RecruitingIRCCS San Raffaele8002021-05-252023-11-29
Metabolic Exercise Test Data Combined with Cardiac and Kidney Indexes (MECKI) Score Evolution: Identification of Cardiovascular Risk in Patients with Heart Failure
Heart Failure
RecruitingCentro Cardiologico Monzino100002021-02-102025-03-19
Effects of Mindfulness Therapy in Patients With Acromegaly and Cushing
Mindfulness, Control - Patient Satisfaction
Not applicableCompletedFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau602020-09-012023-03-16
FAst and SimplE COVID-19 Causing Virus SARS-CoV-2 Detection
Swab sampling - COVID-19
CompletedUniversity of Milano Bicocca2002020-08-012022-04-22
Web-based International Register of Emergency Surgery and Trauma
Emergency General Surgery - Acute Appendicitis, Acute Cholecystitis
RecruitingA.O. Ospedale Papa Giovanni XXIII100002020-07-012020-07-14

Showing 20 of 63. Sign in to see all of them.

Conditions studied

COVID-19 (5)  ·  Coronary Artery Disease (4)  ·  HIV Infections (4)  ·  Thrombosis (4)  ·  Heart Failure (3)  ·  Hematologic Neoplasms (3)  ·  Appendicitis (2)  ·  Brain Injuries, Traumatic (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Wounds and Injuries (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Acute Coronary Syndrome (1)  ·  Arrhythmias, Cardiac (1)  ·  Cardiovascular Diseases (1)  ·  Cholangiocarcinoma (1)

Interventions

Percutaneous Coronary Intervention (2)  ·  Appendectomy (1)  ·  Cell Count (1)  ·  Cetuximab (1)  ·  Cisplatin (1)  ·  Cobicistat (1)  ·  Cyclophosphamide (1)  ·  Cytoreduction Surgical Procedures (1)  ·  Darunavir (1)  ·  Deep Brain Stimulation (1)  ·  Doxorubicin (1)  ·  Ertapenem (1)  ·  Everolimus (1)  ·  Gemcitabine (1)  ·  Hematologic Tests (1)

Countries

Italy (57)  ·  Germany (3)  ·  Spain (2)  ·  Austria (1)  ·  Belgium (1)  ·  Canada (1)  ·  Czechia (1)  ·  Ireland (1)  ·  Latvia (1)  ·  Netherlands (1)  ·  Norway (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Giulio Guagliumi, MD (7)  ·  Alessandro Rambaldi, MD (5)  ·  Franco Maggiolo, MD (3)  ·  Alessandro AR Rambaldi, Professor (1)  ·  Alfonso W Avolio, MD (1)  ·  Anna Falanga, MD (1)  ·  Anthony H Gershlick (1)  ·  Armando Santoro, MD (1)  ·  Bruno Ferraro, MD (1)  ·  Claudio Celentano, MD (1)  ·  Cortelazzo Sergio, MD (1)  ·  Dario Tartaglia, MD (1)  ·  Eugenia Resmini, MD, PhD (1)  ·  Federica Casiraghi (1)

Results publications

PMID 11255275, PMID 11441933, PMID 12011122, PMID 12149300, PMID 12652460, PMID 15090796, PMID 15097290, PMID 16107348, PMID 16732175, PMID 16980990, PMID 17151341, PMID 17606446, PMID 18468541, PMID 18703664, PMID 18820709, PMID 19462317, PMID 20350611, PMID 20488410, PMID 20630463, PMID 20685246, PMID 21393326, PMID 21417678, PMID 21777886, PMID 22298797, PMID 22431208, PMID 23216616, PMID 24467608, PMID 26279673, PMID 28239409, PMID 29963053, PMID 31602518, PMID 32014041, PMID 32129855, PMID 32833107, PMID 34276706, PMID 35485333, PMID 36326921, PMID 37010298, PMID 37160552, PMID 41884465, PMID 8636765

NIH funding

2008 (1)